• Home
  • A-B index
  • Pharmacological Index
  • Drug Classes
  • Active Ingredients
  • Companies
  • News
  • Imodium Capsules
    / Janssen


    Active Ingredient
    Loperamide (HCl) 2 mg

    Status in Israel
    OTC

    Presentation and Status in Health Basket

    Presentation Basket Yarpa Pharmasoft

    Capsules

    10 X 2 mg

    full basket chart 1010 9019

    Related information


    Dosage

    Children above 12 years and Adults: The starting dose is 2 capsules (4 mg). Continue treatment with 1 capsule (2 mg), after each loose (soft) stool. The maximum daily dose is 8 capsules per day (16 mg).
    Special populations
    Children aged between 6 and 12 years: The following dosages should not be exceeded:
    Six to eight years: 2 mg b.i.d. (4mg daily dose) (20 to 30 kg)
    Eight to twelve years: 2 mg t.i.d. (6mg daily dose) (greater than 30 kg)
    Following the first treatment day, it is recommended that subsequent IMODIUM doses be administered only after a loose stool. Total daily dosage should not exceed recommended dosages for the first day.
    The data available regarding the use of loperamide HCl in children under the age of 12 years are limited.
    Elderly: No dose adjustment is required in the elderly.
    Renal impairment: No dose adjustment is required in patients with impaired renal function.
    Hepatic impairment: Although no pharmacokinetic data are available in patients with hepatic impairment, loperamide HCl should be used with caution in these patients due to reduced first-pass metabolism.
    Method of administration: Oral use. The capsules should be taken with liquid.
    Attention: Do not use for more than 2 days. In all cases, discontinue treatment on the normalization of the feces, or if the patient has no further bowel movements for 12 hours, or in the event of constipation. In episodes of acute diarrhea, loperamide HCl is generally able to stop symptoms within 48 hours. If there are no appreciable results after this period, discontinue treatment and consult your doctor.


    Indications

    Symptomatic control of diarrhea.


    Contra-Indications

    See package insert (OTC).


    Special Precautions

    See package insert (OTC).


    Side Effects

    See package insert (OTC).


    Drug interactions

    Broad spectrum antibiotics in patients with pseudomembranous colitis opioid analgesics.
    See package insert (OTC).


    Manufacturer
    Janssen Cilag SA – Val de Reuil, France
    Licence holder
    CLOSE